A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

Recruiting

Early Phase 1

A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors

Sponsor:

Pure Biologics S.A.

Code:

NCT06273852

Conditions

Head and Neck Squamous Cell Carcinoma

Soft Tissue Sarcoma Adult

Triple Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PBA-0405

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Pure Biologics S.A. on 2024-10-09.